Sandbox john: Difference between revisions

Jump to navigation Jump to search
Line 205: Line 205:
</font>
</font>
</div>
</div>
<div class="mw-customtoggle-table04" style="cursor: pointer; border-radius: 0 0 0 0; border: solid 1px #20538D; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: inset 0 1px 1px rgba(255, 255, 255, 0.5), 0 1px 1px rgba(0, 0, 0, 0.5); height: 30px; line-height: 30px; width: 400px; background: #4479BA;">
<div class="mw-customtoggle-table05" style="cursor: pointer; border-radius: 0 0 0 0; border: solid 1px #20538D; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: inset 0 1px 1px rgba(255, 255, 255, 0.5), 0 1px 1px rgba(0, 0, 0, 0.5); height: 30px; line-height: 30px; width: 400px; background: #4479BA;">
<font color="#FFF">
<font color="#FFF">
&nbsp;&nbsp;▸&nbsp;&nbsp;'''''Staphylococci'''''
&nbsp;&nbsp;▸&nbsp;&nbsp;'''''Staphylococci'''''
</font>
</font>
</div>
</div>
<div class="mw-customtoggle-table04" style="cursor: pointer; border-radius: 0 0 0 0; border: solid 1px #20538D; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: inset 0 1px 1px rgba(255, 255, 255, 0.5), 0 1px 1px rgba(0, 0, 0, 0.5); height: 30px; line-height: 30px; width: 400px; background: #4479BA;">
<div class="mw-customtoggle-table06" style="cursor: pointer; border-radius: 0 0 0 0; border: solid 1px #20538D; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: inset 0 1px 1px rgba(255, 255, 255, 0.5), 0 1px 1px rgba(0, 0, 0, 0.5); height: 30px; line-height: 30px; width: 400px; background: #4479BA;">
<font color="#FFF">
<font color="#FFF">
&nbsp;&nbsp;▸&nbsp;&nbsp;'''''Listeria monocytogenes'''''
&nbsp;&nbsp;▸&nbsp;&nbsp;'''''Listeria monocytogenes'''''
</font>
</font>
</div>
</div>
<div class="mw-customtoggle-table04" style="cursor: pointer; border-radius: 0 0 0 0; border: solid 1px #20538D; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: inset 0 1px 1px rgba(255, 255, 255, 0.5), 0 1px 1px rgba(0, 0, 0, 0.5); height: 30px; line-height: 30px; width: 400px; background: #4479BA;">
<div class="mw-customtoggle-table07" style="cursor: pointer; border-radius: 0 0 0 0; border: solid 1px #20538D; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: inset 0 1px 1px rgba(255, 255, 255, 0.5), 0 1px 1px rgba(0, 0, 0, 0.5); height: 30px; line-height: 30px; width: 400px; background: #4479BA;">
<font color="#FFF">
<font color="#FFF">
&nbsp;&nbsp;▸&nbsp;&nbsp;'''''Haemophilus influenzae'''''
&nbsp;&nbsp;▸&nbsp;&nbsp;'''''Haemophilus influenzae'''''
</font>
</font>
</div>
</div>
<div class="mw-customtoggle-table04" style="cursor: pointer; border-radius: 0 0 0 0; border: solid 1px #20538D; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: inset 0 1px 1px rgba(255, 255, 255, 0.5), 0 1px 1px rgba(0, 0, 0, 0.5); height: 30px; line-height: 30px; width: 400px; background: #4479BA;">
<div class="mw-customtoggle-table08" style="cursor: pointer; border-radius: 0 0 0 0; border: solid 1px #20538D; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: inset 0 1px 1px rgba(255, 255, 255, 0.5), 0 1px 1px rgba(0, 0, 0, 0.5); height: 30px; line-height: 30px; width: 400px; background: #4479BA;">
<font color="#FFF">
<font color="#FFF">
&nbsp;&nbsp;▸&nbsp;&nbsp;'''''Streptococcus agalactiae'''''
&nbsp;&nbsp;▸&nbsp;&nbsp;'''''Streptococcus agalactiae'''''
</font>
</font>
</div>
</div>
<div class="mw-customtoggle-table04" style="cursor: pointer; border-radius: 0 0 0 0; border: solid 1px #20538D; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: inset 0 1px 1px rgba(255, 255, 255, 0.5), 0 1px 1px rgba(0, 0, 0, 0.5); height: 30px; line-height: 30px; width: 400px; background: #4479BA;">
<div class="mw-customtoggle-table09" style="cursor: pointer; border-radius: 0 0 0 0; border: solid 1px #20538D; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: inset 0 1px 1px rgba(255, 255, 255, 0.5), 0 1px 1px rgba(0, 0, 0, 0.5); height: 30px; line-height: 30px; width: 400px; background: #4479BA;">
<font color="#FFF">
<font color="#FFF">
&nbsp;&nbsp;▸&nbsp;&nbsp;'''''Bacteroides fragilis'''''
&nbsp;&nbsp;▸&nbsp;&nbsp;'''''Bacteroides fragilis'''''
</font>
</font>
</div>
</div>
<div class="mw-customtoggle-table05" style="cursor: pointer; border-radius: 0 0 5px 5px; border: solid 1px #20538D; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: inset 0 1px 1px rgba(255, 255, 255, 0.5), 0 1px 1px rgba(0, 0, 0, 0.5); height: 30px; line-height: 30px; width: 400px; background: #4479BA;">
<div class="mw-customtoggle-table10" style="cursor: pointer; border-radius: 0 0 5px 5px; border: solid 1px #20538D; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: inset 0 1px 1px rgba(255, 255, 255, 0.5), 0 1px 1px rgba(0, 0, 0, 0.5); height: 30px; line-height: 30px; width: 400px; background: #4479BA;">
<font color="#FFF">
<font color="#FFF">
&nbsp;&nbsp;▸&nbsp;&nbsp;'''''Fusobacterium spp.'''''
&nbsp;&nbsp;▸&nbsp;&nbsp;'''''Fusobacterium spp.'''''

Revision as of 16:34, 28 March 2014

Multiple Tables

  • 1.
Unfavorable Prognostic Factors
  ▸  Presenting with encephalopathy or coma
  ▸  Younger than 10 years or elderly
  ▸  Late start of antibiotics
  ▸  Sterile cultures
Favorable prognostic factors
  ▸  Craniotomy instead of burr holes as surgical procedure
  ▸  Early treatment
  ▸  Young age (optimal between 10-20 years)
  ▸  Patient presents awake, alert and oriented
  ▸  Source of infection: paranasal sinuses
  ▸  Aerobic streptococci isolated in culture
  ▸  Aerobic streptococci as single pathogen
  • 2.

Unfavorable Prognostic Factors
  ▸  Presenting with encephalopathy or coma
  ▸  Younger than 10 years or elderly
  ▸  Late start of antibiotics
  ▸  Sterile cultures
Favorable Prognostic Factors
  ▸  Craniotomy instead of burr holes as surgical procedure
  ▸  Early treatment
  ▸  Young age (optimal between 10-20 years)
  ▸  Patient presents awake, alert and oriented
  ▸  Source of infection: paranasal sinuses
  ▸  Aerobic streptococci isolated in culture
  ▸  Aerobic streptococci as single pathogen

  • 3.
Cardiovascular No underlying causes
Chemical/Poisoning No underlying causes
Dental No underlying causes
Dermatologic No underlying causes
Drug Side Effect No underlying causes
Ear Nose Throat No underlying causes
Endocrine No underlying causes
Environmental No underlying causes
Gastroenterologic No underlying causes
Genetic No underlying causes
Hematologic No underlying causes
Iatrogenic No underlying causes
Infectious Disease No underlying causes
Musculoskeletal/Orthopedic No underlying causes
Neurologic No underlying causes
Nutritional/Metabolic No underlying causes
Obstetric/Gynecologic No underlying causes
Oncologic No underlying causes
Ophthalmologic No underlying causes
Overdose/Toxicity No underlying causes
Psychiatric No underlying causes
Pulmonary No underlying causes
Renal/Electrolyte No underlying causes
Rheumatology/Immunology/Allergy No underlying causes
Sexual No underlying causes
Trauma No underlying causes
Urologic No underlying causes
Miscellaneous No underlying causes

Play Time

Pathogen-Based Therapy

  ▸  Neisseria meningitidis

  ▸  Streptococcus pneumoniae

  ▸  Gram negative bacilli

  ▸  Pseudomonas aeruginosa

  ▸  Staphylococci

  ▸  Listeria monocytogenes

  ▸  Haemophilus influenzae

  ▸  Streptococcus agalactiae

  ▸  Bacteroides fragilis

  ▸  Fusobacterium spp.

Infants < 1 month
Preferred Regimen
Ampicillin 200 mg/kg/day IV, q4h
PLUS
Cefotaxime 200 mg/kg/day IV, q6h
Infants 1-3 months
Preferred Regimen
Ampicillin 200 mg/kg/day IV, q4h
PLUS
Cefotaxime 200 mg/kg/day IV, q6h
OR
Ceftriaxone 100 mg/kg/day IV, q12h
> 3 months Immunocompetent Children; Adults < 55 years
Preferred Regimen
Vancomycin Child: 60 mg/kg/day IV, q6h; Adult: 2 g/day IV, q12h
PLUS
Cefotaxime Child: 200 mg/kg/day IV, q6h; Adult: 12 g/day IV, q4h
OR
Ceftriaxone Child: 100 mg/kg/day IV, q12h; Adult: 4 g/day IV, q12h
OR
Cefepime Child: 150 mg/kg/day IV, q8h; Adult: 6 g/day IV, q8h
Might be added Metronidazole Child: 30 mg/kg/day, q6h; Adult: 1500-2000 mg/day, q6h
Adults > 55 years; Alcoholics; Debilitating Illness
Preferred Regimen
Ampicillin Child: 200 mg/kg/day IV, q4h; Adult: 12 g/day IV, q4h
PLUS
Vancomycin Child: 60 mg/kg/day IV, q6h; Adult: 2 g/day IV, q12h
PLUS
Cefotaxime Child: 200 mg/kg/day IV, q6h; Adult: 12 g/day IV, q4h
OR
Ceftriaxone Child: 100 mg/kg/day IV, q12h; Adult: 4 g/day IV, q12h
OR
Cefepime Child: 150 mg/kg/day IV, q8h; Adult: 6 g/day IV, q8h
Specific Situations
Preferred Regimen
Ampicillin Child: 200 mg/kg/day IV, q4h; Adult: 12 g/day IV, q4h
PLUS
Vancomycin Child: 60 mg/kg/day IV, q6h; Adult: 2 g/day IV, q12h
PLUS
Ceftazidime Child: 150 mg/kg/day IV, q8h; Adult: 6 g/day IV, q8h
OR
Meropenem Child: 120 mg/kg/day IV, q8h; Adult: 3 g/day IV, q8h
Hospital Acquired Meningitis; Posttraumatic Meningitis; Postneurosurgery   Meningitis; Neutropenia; Impaired Cell-mediated Immunity